Aptamer Group (APTA.L) Stock Price

£0.725 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    1

  • Technical

    7

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Aptamer Group, AI stock picks, stock alerts and much more.

Sign up

APTA.L AI Stock Analysis

AI stock analysis for APTA.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Aptamer Group (APTA.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Aptamer Group (APTA.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Aptamer Group (APTA.L), currently trading at £0.725, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About APTA.L

LSE

  • Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally.

  • Symbol

    APTA.L

  • Market

    LSE

  • Industry

    Biotechnology

  • Market Cap

    19.3M

Similar Stocks

0I0X.L Codexis
0I0X.L		 $2.82
0.9%
5
ONT.L Oxford Nanopore Technologies plc
ONT.L		 £208.2
1.3%
7
SAR.L Sareum Holdings
SAR.L		 £22
8.3%
5
0K1R.L Viridian Therapeutics
0K1R.L		 $19.44
9.9%
6
AVCT.L Avacta Group Plc
AVCT.L		 £49
1%
4

News

Evaluating patients with chest pain in the emergency department

Evaluating patients with chest pain in the emergency department
March 28, 2025. The BMJ
New ways to combat the threat of antimicrobial resistance (AMR)

New ways to combat the threat of antimicrobial resistance (AMR)
November 18, 2024. The Star Online
Level Zero Health is working on a potentially life-changing device for hormone health | TechCrunch

Level Zero Health is working on a potentially life-changing device for hormone health | TechCrunch
October 28, 2024. TechCrunch
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
September 16, 2024. The BMJ

APTA.L Alternative Data

Web Traffic

Aptamer Group receives an estimated 5901 monthly visitors to aptamergroup.com.

  • Web Traffic

    5901

  • Change from Previous Month

    30%

  • 3 Month Change

    49.8%

  • YoY Change

    49.8%

Facebook Engagement

Aptamer Group has engaged 3 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    3

  • Daily Change

    50%

  • 1 Month Change

    40%

  • 3 Month Change

    25%

  • YoY Change

    25%

Instagram Followers

Aptamer Group has 140 Instagram Followers on its main Instagram account, up by 0.7% over the last month.

  • Instagram Followers

    140

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    1.4%

  • YoY Change

    1.4%

Youtube Subscribers

Aptamer Group has 191 subscribers on its main Youtube channel, up by 2.7% over the last month.

  • Youtube Subscribers

    191

  • Daily Change

    0%

  • 1 Month Change

    2.7%

  • 3 Month Change

    5.5%

  • YoY Change

    5.5%

Job Postings

Aptamer Group currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Twitter Followers

Aptamer Group has 1,324 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.

  • Twitter Followers

    1324

  • Daily Change

    0.1%

  • 1 Month Change

    0.7%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

LinkedIn Followers

5,645 are following Aptamer Group on LinkedIn, up by 1.8% over the last month.

  • LinkedIn Followers

    5645

  • Daily Change

    1.8%

  • 1 Month Change

    1.8%

  • 3 Month Change

    5%

  • YoY Change

    5%

LinkedIn Employees

According to LinkedIn, Aptamer Group has 36 employees.

  • LinkedIn Employees

    36

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    5.9%

  • YoY Change

    5.9%

Business Outlook

According to employee reviews, the business outlook among employees at Aptamer Group is 55 out of 100 (neutral).

  • Business Outlook

    55

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Aptamer Group was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Aptamer Group has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

APTA.L Financials

APTA.L Key Metrics

  • Total Revenue

    £653K

  • Net Income

    -£1.1M

  • Earnings per Share

    -£0.0007

  • Free cash flow

    -£1.3M

  • EBITDA

    -£1.1M

  • EBITDA Ratio

    -1.683

  • Total Assets

    £4.3M

APTA.L 2-year Revenue & Income
APTA.L 2-year Free Cash Flow

APTA.L Technicals

APTA.L SMA
APTA.L RSI

FAQ

What's the current price of Aptamer Group (APTA.L) Stock?
The price of an Aptamer Group (APTA.L) share is £0.725.

What's the market cap of Aptamer Group?
The current market cap of Aptamer Group is 19.3M.

Should I buy or sell APTA.L?
Aptamer Group shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Aptamer Group is better viewed as a hold or accumulate position while waiting for further developments.

Is Aptamer Group a good investment?
The current analysis of Aptamer Group's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Aptamer Group's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Aptamer Group (APTA.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Aptamer Group stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Aptamer Group (APTA.L) that investors often compare it to?
Aptamer Group (APTA.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.

What is the forecast for Aptamer Group's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Aptamer Group's stock price to be around £0.756 in 2026. Starting from the current price of £0.725, this represents a 4.3% change in price, indicating a neutral outlook for the stock.

How to buy Aptamer Group (APTA.L) Stock?
Aptamer Group stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Aptamer Group shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.